佰仁医疗收盘下跌1.46%，滚动市盈率81.03倍，总市值138.16亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Baijun Medical, indicating a high PE ratio compared to industry averages [1][2] - As of June 19, Baijun Medical's closing price was 100.56 yuan, with a PE ratio of 81.03, significantly higher than the industry average of 48.08 [1][2] - The total market capitalization of Baijun Medical is 13.816 billion yuan, ranking it 102nd in the medical device industry based on PE ratio [1][2] Group 2 - Baijun Medical's main business includes the research, production, sales, and service of medical devices, with key products such as biological patches for cardiac and thoracic surgery, artificial heart valves, and other surgical implant devices [1] - In the first quarter of 2025, Baijun Medical reported revenue of 100 million yuan, a year-on-year increase of 31.30%, and a net profit of 32.5043 million yuan, reflecting a significant year-on-year growth of 290.69% [1] - The gross profit margin for Baijun Medical stands at 85.72%, indicating strong profitability in its operations [1]